Healthcare utilization in cancer survivors: six-month longitudinal cohort data

• Published in: Cancer causes & control Vol. 33; no. 7; pp. 1005 - 1012
• Main Authors: Gonzalez, Nicole, Mead, K. Holly, Pratt-Chapman, Mandi L., Arem, Hannah
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.07.2022; Springer Nature B.V
• Subjects: Biomedical and Life Sciences; Biomedicine; Breast cancer; Cancer; Cancer Research; Cancer Survivors; Colorectal carcinoma; Delay; Epidemiology; Health care; Health services; Health services utilization; Hematology; Humans; Male; Neoplasms - epidemiology; Neoplasms - therapy; Oncology; Original Paper; Patient Acceptance of Health Care; Pharmacists; Prostate; Prostate cancer; Public Health; Quality of Life; Regression analysis; Surveys and Questionnaires; Survival; Survivor; Survivors; Utilization; Survivorship; Healthcare utilization; Cancer
• ISSN: 0957-5243; 1573-7225
• DOI: 10.1007/s10552-022-01587-6

Purpose To describe healthcare utilization and reasons for delaying medical care and to identify factors that influence high healthcare utilization and care delay among cancer survivors. Methods Baseline ( n  = 991) and 6 month follow-up data ( n  = 777) were collected among breast, prostate, and colorectal cancer survivors from 32 US cancer centers. Participants completed surveys on healthcare utilization (e.g., number of visits to specific providers) and delay of medical care. We categorized participants as high or low users based on median number of visits. We used logistic regression models to examine factors that predicted high healthcare utilization or delay. Results Survivors reported a median of 10.5 visits to healthcare providers and 28% reported ever delaying medical care over 6 months. Compared to prostate cancer survivors, breast and colorectal survivors were 2.4 times more likely (CI = 1.2–4.8) and 4 times more likely (CI = 2.2–7.3) to be high healthcare users, respectively. A higher quality of life score predicted high healthcare utilization (OR = 2.4, CI = 2.0–2.8) and delay of medical care (OR = 1.8, CI = 1.5–2.2). Black survivors were 1.5 times more likely than White survivors to be high healthcare users (CI = 1.1–2.0) and respondents reporting a race category other than White or Black were 1.8 times more likely to delay care (CI = 1.3–2.5). Lower levels of self-efficacy predicted greater healthcare use (OR = 0.7, CI = 0.6–0.8) and delay (OR = 0.6, CI = 0.5–0.7). Conclusion Our findings suggest that race, education, marital status, cancer type, time since diagnosis, quality of life, and self-efficacy are associated with both high healthcare utilization and delay among cancer survivors.